Interactions of amphotericin B derivatives with lipid membranes-A molecular dynamics study

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 10, 2007, Pages 2616-2626

  Czub, Jacek ^a   Borowski, Edward ^a   Baginski, Maciej ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Amphotericin B; Cholesterol; Ergosterol; Lipid membranes; Molecular dynamics; Molecular modeling

Indexed keywords

AMPHOTERICIN B; CHOLESTEROL; ERGOSTEROL; N (1 PIPERIDINEPROPIONYL)AMPHOTERICIN B METHYL ESTER; N(N' 3 DIMETHYLAMINOPROPYLSUCCINIMIDO)AMPHOTERICIN B METHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG MECHANISM; DRUG SYNTHESIS; FUNGAL CELL; HYDROPHILICITY; LABORATORY; LIPID BILAYER; LIPID MEMBRANE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; SIMULATION;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CELL MEMBRANE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPID BILAYERS;

ANIMALIA;

EID: 34948885100     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.06.017     Document Type: Article

References (49)

1. Gallis H.A., Drew R.H., and Pickard W.W. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12 (1990) 308-329
2. Hartsel S., and Bolard J. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 17 (1996) 445-449
3. Barrett J.P., Vardulaki K.A., Conlon C., Cooke J., Daza-Ramirez P., Evans E.G.V., Hawkey P.M., Herbrecht R., Marks D.I., Moraleda J.M., Park G.R., Senn S.J., and Viscoli C. A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin. Ther. 25 (2003) 1295-1320
4. Ostrosky-Zeichner L., Marr K.A., Rex J.H., and Cohen S.H. Amphotericin B: time for a new "gold standard". Clin. Infect. Dis. 37 (2003) 415-425
5. Kleinberg M. What is the current and future status of conventional amphotericin B?. Int. J. Antimicrob. Agents 27 (2006) S12-S16
6. Wong-Beringer A., Jacobs R.A., and Guglielmo B.J. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin. Infect. Dis. 27 (1998) 603-618
7. Borowski E. Novel approaches in the rational design of antifungal agents of low toxicity. Farmaco 55 (2000) 206-208
8. Cereghetti D.M., and Carreira E.M. Amphotericin B: 50 years of chemistry and biochemistry. Synthesis (Stuttg.) (2006) 914-942
9. Gale E.F. Mode of action and resistance mechanisms of polyene macrolides. In: Omura S. (Ed). Macrolide antibiotics (1984), Academic Press, Inc., Orlando 425-455
10. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim. Biophys. Acta 864 (1986) 257-304
11. Hartsel S.C., Hatch C., and Ayenew W. How does amphotericin B work? studies on model membrane systems. J. Liposome. Res. 3 (1993) 377-408
12. Medoff G., Brajtburg J., Kobayashi G.S., and Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu. Rev. Pharmacol. Toxicol. 23 (1983) 303-330
13. Teerlink T., De Kruijff B., and Demel R.A. The action of pimaricin, etruscomycin and amphotericin B on liposomes with varying sterol content. Biochim. Biophys. Acta 599 (1980) 484-492
14. Paquet M.J., Fournier I., Barwicz J., Tancrede P., and Auger M. The effects of amphotericin B on pure and ergosterol- or cholesterol- containing dipalmitoylphosphatidylcholine bilayers as viewed by H-2 NMR. Chem. Phys. Lipids 119 (2002) 1-11
15. Baginski M., Cybulska B., and Gruszecki W.I. Interaction of polyene macrolide antibiotics with lipid model membranes. In: Leitmannova-Liu A. (Ed). Advances in planar lipid bilayers and liposomes vol. 3 (2006), Elsevier, Amsterdam 269-329
16. Mazerski J., Bolard J., and Borowski E. Effect of modifications of ionizable groups of amphotericin B on its ability to form complexes with sterols in hydroalcoholic media. Biochim. Biophys. Acta 1236 (1995) 170-176
17. Bolard J., Legrand P., Heitz F., and Cybulska B. One-side action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 30 (1991) 5707-5715
18. Cybulska B., Gadomska I., Mazerski J., Grzybowska J., Borowski E., Cheron M., and Bolard J. N-methyl-N-d-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity. Acta Biochim. Pol. 47 (2000) 121-131
19. Szlinder-Richert J., Mazerski J., Cybulska B., Grzybowska J., and Borowski E. MFAME, N-methyl-N-d-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self- association and effects on red blood cells. Biochim. Biophys. Acta 1528 (2001) 15-24
20. Hac-Wydro K., Dynarowicz-Latka P., Grzybowska J., and Borowski E. N-(1-piperidinepropionyl)amphotericin B methyl ester (PAME)-A new derivative of the antifungal antibiotic amphotericin B: searching for the mechanism of its reduced toxicity. J. Colloid Interface Sci. 287 (2005) 476-484
21. Szlinder-Richert J., Cybulska B., Grzybowska J., Bolard J., and Borowski E. Interaction of amphotericin B and its low toxic derivative, N-methyl-N-d-fructosyl amphotericin B methyl ester, with fungal, mammalian and bacterial cells measured by the energy transfer method. Farmaco 59 (2004) 289-296
22. Feller S.E. Molecular dynamics simulations of lipid bilayers. Curr. Opin. Colloid Interface Sci. 5 (2000) 217-223
23. Scott H.L. Modeling the lipid component of membranes. Curr. Opin. Struck. Biol. 12 (2002) 495-502
24. Saiz L., Bandyopadhyay D., and Klein M.L. Towards an understanding of complex biological membranes from atomistic molecular dynamics simulations. Biosci. Rep. 22 (2003) 151-173
25. J. Bolard, C.H. Garcia, O. Seksek, E. Borowski, J. Grzybowska, Polyene macrolide derivatives, use for vectoring molecules, Polish Patent Application No P-343365 (1999).
26. Czerwinski A., Konig W.A., Zieniawa T., Sowinski P., Sinnwell V., Milewski S., and Borowski E. New N-alkyl derivatives of amphotericin B. Synthesis and biological properties. J. Antibiot. 44 (1991) 979-984
27. Slisz M., Cybulska B., Mazerski J., Grzybowska J., and Borowski E. Studies of the effects of antifungal cationic derivatives of amphotericin B on human erythrocytes. J. Antibiot. 57 (2004) 669-678
28. Baginski M., Resat H., and Borowski E. Comparative molecular dynamics simulations of amphotericin B- cholesterol/ergosterol membrane channels. Biochim. Biophys. Acta 1567 (2002) 63-78
29. Resat H., and Baginski M. Ion passage pathways and thermodynamics of the amphotericin B membrane channel. Eur. Biophys. J. Biophys. Lett. 31 (2002) 294-305
30. Sternal K., Czub J., and Baginski M. Molecular aspects of the interaction between amphotericin B and a phospholipid bilayer: molecular dynamics studies. J. Mol. Model. 10 (2004) 223-232
31. Czub J., and Baginski M. Modulation of amphotericin B membrane interaction by cholesterol and ergosterols-A molecular dynamics study. J. Phys. Chem., B 110 (2006) 16743-16753
32. Czub J., and Baginski M. Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol. Biophys. J. 90 (2006) 2368-2382
33. K. Sternal, Molecular Properties and Interactions of Supramolecular Systems Formed by Amphotericin B Derivatives: Analysis by Computational Chemistry Methods-Doctoral Thesis, Gdansk University of Technology, Gdansk, 2005.
34. Humphrey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 14 (1996) 33-38
35. Lindahl E., Hess B., and van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Model. 7 (2001) 306-317
36. Berger O., Edholm O., and Jahnig F. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature. Biophys. J. 72 (1997) 2002-2013
37. Baginski M., Sternal K., Czub J., and Borowski E. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic. Acta Biochim. Pol. 52 (2005) 655-658
38. Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., and Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 103 (1995) 8577-8593
39. Hess B., Bekker H., Berendsen H.J.C., and Fraaije J.G.E.M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18 (1997) 1463-1472
40. Miyamoto S., and Kollman P.A. SETTLE-An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13 (1992) 952-962
41. Lopes S., and Castanho M.A.R.B. Revealing the orientation of Nystatin and Amphotericin B in lipidic multilayers by UV-Vis linear dichroism. J. Phys. Chem., B 106 (2002) 7278-7282
42. Milhaud J., and Michels B. Binding of nystatin and amphotericin B with sterol-free l-dilauroylphosphatidylcholine bilayers resulting in the formation of dichroic lipid superstructures. Chem. Phys. Lipids 101 (1999) 223-235
43. Simons K., and Vaz W.L.C. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 269-295
44. Herve M., Debouzy J.C., Borowski E., Cybulska B., and Gary-Bobo C.M. The role of the carboxyl and amino groups of polyene macrolides in their interactions with sterols and their selective toxicity. A 31P-NMR study. Biochim. Biophys. Acta 980 (1989) 261-272
45. Matsuoka S., Ikeuchi H., Matsumori N., and Murata M. Dominant formation of a single-length channel by amphotericin B in dimyristoylphosphatidylcholine membrane evidenced by C-13-P-31 rotational echo double resonance. Biochemistry 44 (2005) 704-710
46. Minones J., Minones J., Conde O., Patino J.M.R., and Dynarowicz-Latka P. Mixed monolayers of amphotericin B-dipalmitoyl phosphatidyl choline: study of complex formation. Langmuir 18 (2002) 2817-2827
47. Matsumori N., Sawada Y., and Murata M. Mycosamine orientation of amphotericin B controlling interaction with ergosterol: sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge. J. Am. Chem. Soc. 127 (2005) 10667-10675
48. Resat H., Sungur F.A., Baginski M., Borowski E., and Aviyente V. Conformational properties of amphotericin B amide derivatives - impact on selective toxicity. J. Comput-Aided Mol. Des. 14 (2000) 689-703
49. Baginski M., Resat H., and McCammon J.A. Molecular properties of amphotericin B membrane channel: a molecular dynamics simulation. Mol. Pharmacol. 52 (1997) 560-570